Organ transplants are a miracle of modern medicine. The surgical procedure was first performed in the UK in the 1960s, with the national donor register set up in the mid-1990s. The number of operations performed has increased steadily, going over the 5,000 mark for the first time in the year 2017/18.
While not the huge deal they once were – surgically at least – the life-changing nature of the operation for patients has arguably become greater over the years as procedures are more streamlined and medication regimens simpler and less risky.
This patient group requires special attention because of the need to take anti-rejection drugs after the transplant operation in order to stop the body’s immune system from attacking the donated organ.
Transplant patients are put on a regimen of immunosuppressant therapy, which may include the following:
With thanks to Mona Koshkouei, clinical standards manager at Celesio UK, for her help in putting together this article.